Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 919.6	$ 802.1
Accounts receivable, less allowance for credit losses	1,392.0	1,452.7
Inventories	2,517.4	2,450.7
Prepaid taxes	314.7	208.8
Prepaid expenses and other current assets	168.7	169.0
Total Current Assets	5,312.4	5,083.3
Property, plant and equipment, net	2,008.2	2,047.7
Goodwill	9,212.0	9,261.8
Intangible assets, net	6,470.3	7,055.5
Other assets	1,005.7	969.4
Total Assets	24,008.6	24,417.7
Current Liabilities:
Accounts payable	327.6	330.0
Income taxes payable	121.2	59.5
Other current liabilities	1,444.6	1,667.4
Current portion of long-term debt	1,045.7	500.0
Total Current Liabilities	2,939.1	2,556.9
Deferred income taxes, net	693.9	790.4
Long-term income tax payable	596.6	588.1
Other long-term liabilities	606.7	656.4
Long-term debt	6,458.1	7,626.5
Total Liabilities	11,294.4	12,218.3
Commitments and Contingencies (Note 17)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 312.7 million shares in 2021 (311.4 million in 2020) issued	3.1	3.1
Paid-in capital	9,295.1	9,121.6
Retained earnings	10,426.3	10,086.9
Accumulated other comprehensive loss	(298.1)	(297.8)
Treasury stock, 103.8 million shares in 2021 (103.8 million shares in 2020)	(6,717.8)	(6,719.6)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,708.6	12,194.2
Noncontrolling interest	5.6	5.2
Total Stockholders' Equity	12,714.2	12,199.4
Total Liabilities and Stockholders' Equity	$ 24,008.6	$ 24,417.7